Sanara MedTech Reports Q1 2026 Earnings with Revenue Growth and Net Profitability

Sanara MedTech (SMTI) reported strong first-quarter earnings for 2026, achieving a 19% revenue growth compared to the same period in 2025. The company reached GAAP net profitability of $0.4 million or $0.04 per diluted share and noted increased demand for its surgical products.

By Motley Fool Transcribing, The Motley Fool Tue, June 2, 2026 at 7:56 PM GMT+3 15 min read · Yahoo Finance ·

Sanara MedTech Reports Q1 2026 Earnings with Revenue Growth and Net Profitability

Tickers: $SMTI

Topics: financial_results profitability revenue_growth

Read the full article at Yahoo Finance

More World news